What Researchers Did
Researchers conducted a literature review on the use of hyperbaric oxygen therapy for head and neck irradiated patients, focusing on osteoradionecrosis.
What They Found
The review found that the widespread use of hyperbaric oxygen therapy for preventing and treating osteoradionecrosis (ORN) in head and neck cancer patients is largely based on personal beliefs and experience. There is no scientific consensus on its efficacy, indicating a critical need for randomized controlled trials to assess its true impact.
What This Means for Canadian Patients
Canadian patients undergoing radiation therapy for head and neck cancer should be aware that the efficacy of hyperbaric oxygen therapy for preventing or treating osteoradionecrosis lacks strong scientific consensus. Decisions regarding this therapy should involve a thorough discussion with their healthcare providers, considering the current evidence base and the need for more robust research.
Canadian Relevance
This review, published in a Canadian journal by Canadian authors, directly addresses a significant complication faced by Canadian head and neck cancer patients. It highlights the need for evidence-based practice in Canada regarding hyperbaric oxygen therapy for osteoradionecrosis.
Study Limitations
As a literature review, this study's findings are limited by the lack of high-quality randomized controlled trials and the existing scientific consensus on hyperbaric oxygen therapy's efficacy.